Atea Pharmaceuticals Inc. (AVIR)
Market Closed
17 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
4. 87
+0.16
+3.2874%
$
376.13M Market Cap
- P/E Ratio
- Div Yield
225,600 Volume
-1.64 Eps
$ 4.71
Previous Close 
Want to track AVIR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Atea Pharmaceuticals Inc. (AVIR) Statistics
Valuation metrics
Market Cap 376.13M
Enterprise value 311.05M
Trailing P/E (ttm) -2.31
Forward P/E -
PEG ratio 0.1
Price/Sales (ttm) -
Price/Book (mrq) 1.65
Enterprise Value/Revenue -
Enterprise Value/EBITDA -1.73
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 238.79K
Average volume (90 days) 309.9K
Price summary
52-Week low 2.78
52-Week high 6.45
Beta -
50-Day moving average 4.65
200-Day moving average 4.83
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.63%
Return on equity -0.57%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.14
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 3.23
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 7.89%
Book value per share (mrq) 2.95
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
